Spanish Red Biotech Pipeline

Amgen

blinatumomab

Type: Biodrugs/ Drugs
Therapeutic area: Blood and Lymphatic systems
Cancer
Indication: Adults with Refractory/Relapsed B-Precursor ALL (B-ALL R/R)
Phase: 1Phase I in Spain